Computerized Tomography as First Coronary Study?

According to this new document recently published in JACC, a computerized tomography (CT) coronary angiography should be the first study done to diagnose a stable coronary artery disease.

ffr tomografia

A multidisciplinary group of experts recommends using computerized tomography as first-line diagnosis in stable patients. According to these professionals, guidelines should be updated soon.

Given the accruing evidence favoring anatomical studies (such as the PROMISE, the SCOT-HEART, and, more recently, the ISCHEMIA), this expert committee believes that computerized tomography offers the greatest benefit for patient management.

Despite the evidence supporting the benefits and even the savings in patients without known coronary disease, reality indicates that, for every 60 gamma-camera studies (single photon emission computed tomography, SPECT) only one tomography is conducted.


Read also: Visual Assessment for Non-Culprit Lesion Revascularization.


his could be partially due to the vast number of centers with nuclear medicine and stress echocardiography, the traditional idea that function supersedes anatomy, and the administrative difficulties faced by health systems in the payment of tomographies.

Both United Kingdom and European guidelines have been updated with the use of CT in chronic coronary syndromes, but the old school approach is still going strong in the United States. There might also be a lack of trained staff who can interpret the images.

We might be reaching a time when computerized tomography scans will completely replace us, and we will only enter the cath lab for therapeutic procedures.

Original Title: Current evidence and recommendations for coronary CTA first in evaluation of stable coronary artery disease.

Reference: Poon M et al. J Am Coll Cardiol. 2020;76:1358-1362.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...